Hope Oncology

Richardson, Texas 75080

0 studies enrolling now · 7 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Malignant Melanoma, NSCLC, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Relapsed Follicular Lymphoma

Studies at this site

• ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer — Stopped early
• A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma — Completed
• Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) — Completed
• Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer — Completed
• Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer — Completed
• Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma — Completed
• Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed